Innovation and Development in the Fibroblast Activation Protein Inhibitor Market
The landscape of the Fibroblast Activation Protein Inhibitor Market is poised for transformative shifts, with projections indicating a market size expansion from $3.144 billion in 2024 to approximately $8.722 billion by 2035. This anticipated growth represents a compound annual growth rate (CAGR) of 9.72%. Experts highlight that increasing cancer prevalence and advancements in drug development...
0 Commentaires 0 Parts 85 Vue 0 Aperçu